Unicycive Therapeutics
UNCY----
Unicycive Therapeutics (UNCY)
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Unicycive Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 9, 2026Price forecast
$38.59614.63%
Forecast & RatingStrong buy
10analysts
- Strong buy80.00%
- Buy20.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Jul 14 at 03:25 AM
Unicycive Therapeutics (UNCY) Gets a Buy from Maxim Group
- MorningStar · Jul 8 at 07:11 PM
UNCY INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Unicycive Therapeutics, Inc.
- PUBT · Jul 6 at 03:04 PM
Unicycive Therapeutics posts corporate presentation on kidney disease pipeline, lead hyperphosphatemia drug OLC
- Tip Ranks · Jul 2 at 09:58 AM
Unicycive Therapeutics Reports Preliminary Q2 2026 Cash Position
- rttnews · Jul 2 at 09:15 AM
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal
- Tip Ranks · Jul 1 at 05:55 AM
Guggenheim Remains a Buy on Unicycive Therapeutics (UNCY)
